International/Africa

Malaria Vaccine Offers Hope

Published in Blood Weekly, March 13th, 1995

A new malaria vaccine, developed by a Colombian scientist, is poised to offer hope to millions of children living in endemic areas in Africa.

Professor Manuel Patarroyo, who developed the vaccine SPF66, reports that World Health Organization (WHO) Director General Hiroshi Nakajima was due to sign an agreement with the Colombian government on February 23, 1995, to set up a plant in the Latin American country for the mass production of the drug.

Much of the vaccine could find its way to Africa, home to 90 percent of the total worldwide clinical malaria cases recorded every year.

Out of the 1.5 to three million malaria deaths...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-03-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry